← All companies
BIOMARIN PHARMACEUTICAL INC
BMRN - CIK 0001048477
Market cap$10.86 B
Rank#899
SEC filings2,709
The table below shows BIOMARIN PHARMACEUTICAL INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.31B | $942.84M | $755.13M | $724.53M | $587.28M | $649.16M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $908.21M | $660.53M | $633.70M | $461.32M | $373.40M | $448.35M |
| Inventory | $1.30B | $1.23B | $1.11B | $894.08M | $776.67M | $698.55M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.